Paclitaxel-Eluting Balloons for Sirolimus-Eluting Stent Restenosis

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2011 English Publisher:Elsevier BVJournal:JACC: Cardiovascular Interventions, volume 4, page 716 (issn: 1936-8798,

Copyright policy )

Authors: Alfonso, Fernando; Dutary, Jaime; Paulo, Manuel; Pérez-Vizcayno, María José;

doi: 10.1016/j.jcin.2011.03.011

pmid: 21700261

Paclitaxel-Eluting Balloons for Sirolimus-Eluting Stent Restenosis

- Summary
- Subjects
- Metrics

Abstract

We read with interest the randomized study by Habara et al. ([1][1]) comparing paclitaxel-eluting balloon (PB) (n = 25) with conventional balloon (BA) (n = 25) in patients suffering from sirolimus-eluting stent (SES) in-stent restenosis (ISR). In these patients, PB provided a dramatic improvement in

Keywords

Coronary Restenosis, Male, Sirolimus, Paclitaxel, Humans, Cardiovascular Agents, Drug-Eluting Stents, Female, Angioplasty, Balloon, Coronary, Cardiology and Cardiovascular Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	6
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average